Position in ACAD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,542,328
-$4,704,067 QoQ
Shares Held
140,013
-62.2% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#88
of 354 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Derivatives in ACAD
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$274,065
PutShares
16,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. ACAD ranks #58 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in ACAD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,542,328 | 140,013 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,246,395 | 370,458 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,087,337 | 40,709 | Shares | Defined | 2026-02-13 | |
| 2025-03-31 | $274,065 | 16,500 | Put | Defined | 2025-08-27 | |
| 2025-03-31 | $790,436 | 47,588 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $3,400,493 | 185,313 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,811,048 | 572,890 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,787,166 | 848,441 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $18,656,095 | 1,008,983 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $373,498 | 20,200 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $8,674,498 | 277,052 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,313,810 | 159,012 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $4,112,734 | 218,530 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $7,786,067 | 475,921 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,970,351 | 494,702 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,834,869 | 199,623 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $711,659 | 30,491 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,919,285 | 115,550 | Shares | Defined | 2021-11-15 | |
| 2020-12-31 | $1,743,651 | 32,616 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $8,649,011 | 209,673 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,205,757 | 66,139 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,351,946 | 79,336 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||